Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)

CUSIP: 05156V102

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / Common Shares, no par value
Shares outstanding
132,929,348
Total 13F shares
23,438,674
Share change
+352,332
Total reported value
$146,961,556
Put/Call ratio
182%
Price per share
$6.27
Number of holders
59
Value change
+$2,094,667
Number of buys
30
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP 05156V102?
CUSIP 05156V102 identifies AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
4.4%
5,867,800
$35,969,000 30 Jun 2017
13F
NEA Management Company, LLC
13F
Company
3.6%
4,808,483
$29,476,000 30 Jun 2017
13F
ORBIMED ADVISORS LLC
13F
Company
1.4%
1,797,400
$11,018,000 30 Jun 2017
13F
FRANKLIN RESOURCES INC
13F
Company
0.94%
1,250,000
$7,663,000 30 Jun 2017
13F
Polar Capital LLP
13F
Company
0.89%
1,183,272
$7,253,000 30 Jun 2017
13F
Vivo Capital, LLC
13F
Company
0.76%
1,013,149
$6,211,000 30 Jun 2017
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.66%
876,461
$5,373,000 30 Jun 2017
13F
Alyeska Investment Group, L.P.
13F
Company
0.5%
669,346
$4,103,000 30 Jun 2017
13F
MORGAN STANLEY
13F
Company
0.42%
563,293
$3,453,000 30 Jun 2017
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.38%
500,000
$3,065,000 30 Jun 2017
13F
Crawford Lake Capital Management, LLC
13F
Company
0.34%
455,369
$2,791,000 30 Jun 2017
13F
AWM Investment Company, Inc.
13F
Company
0.27%
352,500
$2,161,000 30 Jun 2017
13F
Hudson Bay Capital Management LP
13F
Company
0.26%
350,000
$2,146,000 30 Jun 2017
13F
Redmile Group, LLC
13F
Company
0.25%
332,310
$2,037,000 30 Jun 2017
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.19%
255,633
$1,567,000 30 Jun 2017
13F
Nicholas Investment Partners, LP
13F
Company
0.19%
254,084
$1,557,000 30 Jun 2017
13F
Abingworth LLP
13F
Company
0.19%
252,129
$1,543,000 30 Jun 2017
13F
GROUP ONE TRADING LLC
13F
Company
0.18%
235,467
$1,443,000 30 Jun 2017
13F
OTA Financial Group L.P.
13F
Company
0.13%
175,934
$1,291,000 30 Jun 2017
13F
Sculptor Capital LP
13F
Company
0.14%
189,900
$1,164,000 30 Jun 2017
13F
Creative Planning
13F
Company
0.12%
164,265
$1,007,000 30 Jun 2017
13F
IRONWOOD INVESTMENT MANAGEMENT LLC
13F
Company
0.12%
159,092
$975,000 30 Jun 2017
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.11%
151,468
$928,000 30 Jun 2017
13F
S.c.a. Candriam
13F
Individual
0.09%
118,000
$723,000 30 Jun 2017
13F
UBS Group AG
13F
Company
0.07%
98,540
$604,000 30 Jun 2017
13F
A.R.T. Advisors, LLC
13F
Company
0.07%
97,600
$598,000 30 Jun 2017
13F
BANK OF MONTREAL /CAN/
13F
Company
0.07%
86,700
$532,000 30 Jun 2017
13F
Bank of New York Mellon Corp
13F
Company
0.06%
81,950
$502,000 30 Jun 2017
13F
ALPS ADVISORS INC
13F
Company
0.06%
74,107
$454,000 30 Jun 2017
13F
CITADEL ADVISORS LLC
13F
Company
0.06%
73,270
$449,000 30 Jun 2017
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.05%
71,001
$435,000 30 Jun 2017
13F
Kazazian Asset Management, LLC
13F
Company
0.05%
66,304
$406,000 30 Jun 2017
13F
Cutler Group LLC / CA
13F
Company
0.04%
53,441
$327,000 30 Jun 2017
13F
DEUTSCHE BANK AG\
13F
Company
0.04%
50,500
$309,000 30 Jun 2017
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.04%
46,600
$286,000 30 Jun 2017
13F
Virtu KCG Holdings LLC
13F
Company
0.03%
40,460
$248,000 30 Jun 2017
13F
Raymond James Financial Services Advisors, Inc.
13F
Company
0.03%
37,400
$229,000 30 Jun 2017
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.02%
33,099
$203,000 30 Jun 2017
13F
Cutler Capital Management, LLC
13F
Company
0.02%
30,000
$184,000 30 Jun 2017
13F
INVESTMENT CENTERS OF AMERICA INC
13F
Company
0.02%
30,000
$184,000 30 Jun 2017
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.02%
29,000
$178,000 30 Jun 2017
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.02%
27,234
$167,000 30 Jun 2017
13F
NumerixS Investment Technologies Inc
13F
Company
0.02%
25,900
$159,000 30 Jun 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.02%
24,941
$152,000 30 Jun 2017
13F
STATE OF MICHIGAN RETIREMENT SYSTEM
13F
Company
0.02%
22,500
$138,000 30 Jun 2017
13F
Parallax Volatility Advisers, L.P.
13F
Company
0.01%
18,751
$115,000 30 Jun 2017
13F
ROYAL BANK OF CANADA
13F
Company
0.01%
16,968
$104,000 30 Jun 2017
13F
INFRASTRUCTURE CAPITAL ADVISORS, LLC
13F
Company
0.01%
16,628
$102,000 30 Jun 2017
13F
Private Advisor Group, LLC
13F
Company
0.01%
10,000
$62,000 30 Jun 2017
13F
BROWN BROTHERS HARRIMAN & CO
13F
Company
0%
6,500
$40,000 30 Jun 2017
13F

Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q3 2017

As of 30 Sep 2017, Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by 59 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,438,674 shares. The largest 10 holders included FMR LLC, NEA Management Company, LLC, ORBIMED ADVISORS LLC, Polar Capital LLP, FRANKLIN RESOURCES INC, Vivo Capital, LLC, GOLDMAN SACHS GROUP INC, Alyeska Investment Group, L.P., MORGAN STANLEY, and Balyasny Asset Management LLC. This page lists 59 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2017 vs Q2 2017 Across Filers

Q2 2017 holders
64
Q3 2017 holders
59
Holder diff
-5
Investor Q2 2017 Shares Q3 2017 Shares Share Diff Share Chg % Q2 2017 Value $ Q3 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .